Geron Announces Conference Call to Discuss Third Quarter 2015 Financial Results

MENLO PARK, Calif., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) will announce its financial results for the third quarter ended September 30, 2015, on Thursday, November 5, 2015, after the market close. Geron’s management will also host a conference call for analysts and investors on Thursday, November 5, 2015, at 4:30 p.m. Eastern Time to discuss the company’s third quarter results and recent events.

Participants can access the conference call live via telephone by dialing 888-288-0246 (U.S.); 440-996-5682 (international). The conference ID is 69664109. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/8h3xqwwa/lan/en. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through December 5, 2015.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
[email protected]
[email protected]

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Crypto News: Remittix Announces $0.46 Final Price Ahead of Its Market Debut as BNB Price Prediction Targets $1,500
• BofA says investors are increasingly worried about an AI boom-bust cycle